Katelynn S. Madill-Thomsen
Research Subjects
Katelynn S. Madill-Thomsen has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Phillip F. Halloran
Alberta Transplant Applied Genomics Centre, Edmonton, University of Alberta, Canada
14 shared publications - Farsad Eskandary
Medical University of Vienna, Vienna, Austria
4 shared publications - Agnieszka Perkowska-Ptasińska
Warsaw Medical University, Warsaw, Poland
3 shared publications - Gaurav Gupta
Virginia Commonwealth University, Richmond, VA
3 shared publications - Gunilla Einecke
Department of Nephrology, Medizinische Hochschule Hannover, Hannover, Germany
3 shared publications Iman Francis
Henry Ford Transplant Institute, Detroit, MI, USA
3 shared publications
Latest Publications
- Open Access
- 17 November 2025
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (4) , 659-670
Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational study
- 17 November 2025
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (4) , 659-670
Open AccessDefining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational study
- Open Access
- 23 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (1) , 117-130
Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants
- 23 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (1) , 117-130
Open AccessImproving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants
- Open Access
- 7 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (1) , 72-87
Subthreshold rejection activity in many kidney transplants currently classified as having no rejection
- 7 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (1) , 72-87
Open AccessSubthreshold rejection activity in many kidney transplants currently classified as having no rejection
- Open Access
- 31 May 2024
- Published by Portland Press Ltd. in Clinical Science
- Vol. 138 (11) , 663-685
Precision diagnostics in transplanted organs using microarray-assessed gene expression: concepts and technical methods of the Molecular Microscope® Diagnostic System (MMDx)
There is a major unmet need for improved accuracy and precision in the assessment of transplant rejection and tissue injury. Diagnoses relying on histologic and visual assessments demonstrate significant variation between expert observers (as represented by low kappa values) and have limited ability to assess many biological processes that produce little histologic changes, for example, acute injury. Consensus rules and guidelines for histologic diagnosis are useful but may have errors. Risks of over- or under-treatment can be serious: many therapies for transplant rejection or primary diseases are expensive and carry risk for significant adverse effects. Improved diagnostic methods could alleviate healthcare costs by reducing treatment errors, increase treatment efficacy, and serve as useful endpoints for clinical trials of new agents that can improve outcomes. Molecular diagnostic assessments using microarrays combined with machine learning algorithms for interpretation have shown promise for increasing diagnostic precision via probabilistic assessments, recalibrating standard of care diagnostic methods, clarifying ambiguous cases, and identifying potentially missed cases of rejection. This review describes the development and application of the Molecular Microscope® Diagnostic System (MMDx), and discusses the history and reasoning behind many common methods, statistical practices, and computational decisions employed to ensure that MMDx scores are as accurate and precise as possible. MMDx provides insights on disease processes and highly reproducible results from a comparatively small amount of tissue and constitutes a general approach that is useful in many areas of medicine, including kidney, heart, lung, and liver transplants, with the possibility of extrapolating lessons for understanding native organ disease states.
- 31 May 2024
- Published by Portland Press Ltd. in Clinical Science
- Vol. 138 (11) , 663-685
Open AccessPrecision diagnostics in transplanted organs using microarray-assessed gene expression: concepts and technical methods of the Molecular Microscope® Diagnostic System (MMDx)
There is a major unmet need for improved accuracy and precision in the assessment of transplant rejection and tissue injury. Diagnoses relying on histologic and visual assessments demonstrate significant variation between expert observers (as represented by low kappa values) and have limited ability to assess many biological processes that produce little histologic changes, for example, acute injury. Consensus rules and guidelines for histologic diagnosis are useful but may have errors. Risks of over- or under-treatment can be serious: many therapies for transplant rejection or primary diseases are expensive and carry risk for significant adverse effects. Improved diagnostic methods could alleviate healthcare costs by reducing treatment errors, increase treatment efficacy, and serve as useful endpoints for clinical trials of new agents that can improve outcomes. Molecular diagnostic assessments using microarrays combined with machine learning algorithms for interpretation have shown promise for increasing diagnostic precision via probabilistic assessments, recalibrating standard of care diagnostic methods, clarifying ambiguous cases, and identifying potentially missed cases of rejection. This review describes the development and application of the Molecular Microscope® Diagnostic System (MMDx), and discusses the history and reasoning behind many common methods, statistical practices, and computational decisions employed to ensure that MMDx scores are as accurate and precise as possible. MMDx provides insights on disease processes and highly reproducible results from a comparatively small amount of tissue and constitutes a general approach that is useful in many areas of medicine, including kidney, heart, lung, and liver transplants, with the possibility of extrapolating lessons for understanding native organ disease states.
- Open Access
- 26 March 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (8) , 1414-1426
Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival
- 26 March 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (8) , 1414-1426
Open AccessRedefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival
- Open Access
- 30 November 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (3) , 508-518
Molecular states associated with dysfunction and graft loss in heart transplants
- 30 November 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (3) , 508-518
Open AccessMolecular states associated with dysfunction and graft loss in heart transplants
- Open Access
- 11 August 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (12) , 3182-3183
Letter to the Editor Re: Letter by Naesens et al. Microvascular inflammation: Gene expression changes do not necessarily reflect pathogenesis
- 11 August 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (12) , 3182-3183
Open AccessLetter to the Editor Re: Letter by Naesens et al. Microvascular inflammation: Gene expression changes do not necessarily reflect pathogenesis
- 15 February 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (5) , 668-669
The real rejection stands up and displays its complexities
- 15 February 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (5) , 668-669
The real rejection stands up and displays its complexities
- Open Access
- 15 November 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (3) , 909-926
The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study
- 15 November 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (3) , 909-926
Open AccessThe molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study
- Open Access
- 26 April 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (10) , 2964-2965
The Molecular Microscope® Diagnostic System meets eminence-based medicine: A clinician’s perspective
- 26 April 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (10) , 2964-2965
Open AccessThe Molecular Microscope® Diagnostic System meets eminence-based medicine: A clinician’s perspective